Sebela Pharmaceuticals’ product portfolio brings value to patients and physicians, and includes market-leading medicines SUTAB®, SUPREP® BOWEL PREP KIT, and NAFTIN®. We market these and additional products to gastroenterologists, dermatologists, podiatrists, and other specialists, and distribute them throughout the United States. Many of our products are sold outside the U.S. by our international marketing partners.
Full Prescribing information for:Pramosone Cream 1%
By May 31, 2023, all strengths of the Pexeva® brand will be discontinued and no longer available. Suitable alternate products will need to be identified for patients currently taking Pexeva®.